Search research articles
Contact Us
Filters
Showing results (11-20 of 139) with videos related to
Page
of 14
Sort By:
Carcinogenesis
|
May 1, 1999
Nordihydroguairetic acid is a potent inhibitor of ferric-nitrilotriacetate-mediated hepatic and renal toxicity, and renal tumour promotion, in mice
S Ansar, M Iqbal, M Athar
Cancer Letters
|
March 30, 1999
Potassium bromate (KBrO3) induces renal proliferative response and damage by elaborating oxidative stress
U Giri, M Iqbal, M Athar
International Journal of Oncology
|
March 24, 1999
Copper-nitrilotriacetate (Cu-NTA) is a potent inducer of proliferative response both in liver and kidney but is a complete renal carcinogen
U Giri, M Iqbal, M Athar
Carcinogenesis
|
July 27, 2001
Nitroglycerin: a NO donor inhibits TPA-mediated tumor promotion in murine skin
P Trikha, N Sharma, M Athar
Basic & Clinical Pharmacology & Toxicology
|
August 27, 2017
LC-MS-sMRM Method Development and Validation of Different Classes of Pain Panel Drugs and Analysis of Clinical Urine Samples
M Athar Masood, Timothy D Veenstra
Carcinogenesis
|
September 1, 1996
Porphyrin-mediated photosensitization has a weak tumor promoting activity in mouse skin: possible role of in situ-generated reactive oxygen species
U Giri, M Iqbal, M Athar
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|
June 18, 2002
Low iron state is associated with reduced tumor promotion in a two-stage mouse skin carcinogenesis model
G Bhasin, H Kauser, M Athar
Biochemical and Biophysical Research Communications
|
July 17, 1995
Ferric nitrilotriacetate (Fe-NTA) is a potent hepatic tumor promoter and acts through the generation of oxidative stress
M Iqbal, U Giri, M Athar
Nutrition (Burbank, Los Angeles County, Calif.)
|
September 1, 1995
Novel copper superoxide dismutase mimics and damage mediated by O2.-
M Athar, M Iqbal, U Giri
Basic & Clinical Pharmacology & Toxicology
|
November 2, 2020
LC-MS-sMRM method development and validation of different classes of pain panel drugs and analysis of clinical urine samples
M Athar Masood, Timothy D Veenstra
Page
of 14
Search research articles
Search
Showing results (11-20 of 139) with videos related to
Sort By:
Page
of 14
Carcinogenesis
|
May 1, 1999
Nordihydroguairetic acid is a potent inhibitor of ferric-nitrilotriacetate-mediated hepatic and renal toxicity, and renal tumour promotion, in mice
S Ansar, M Iqbal, M Athar
Cancer Letters
|
March 30, 1999
Potassium bromate (KBrO3) induces renal proliferative response and damage by elaborating oxidative stress
U Giri, M Iqbal, M Athar
International Journal of Oncology
|
March 24, 1999
Copper-nitrilotriacetate (Cu-NTA) is a potent inducer of proliferative response both in liver and kidney but is a complete renal carcinogen
U Giri, M Iqbal, M Athar
Carcinogenesis
|
July 27, 2001
Nitroglycerin: a NO donor inhibits TPA-mediated tumor promotion in murine skin
P Trikha, N Sharma, M Athar
Basic & Clinical Pharmacology & Toxicology
|
August 27, 2017
LC-MS-sMRM Method Development and Validation of Different Classes of Pain Panel Drugs and Analysis of Clinical Urine Samples
M Athar Masood, Timothy D Veenstra
Carcinogenesis
|
September 1, 1996
Porphyrin-mediated photosensitization has a weak tumor promoting activity in mouse skin: possible role of in situ-generated reactive oxygen species
U Giri, M Iqbal, M Athar
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|
June 18, 2002
Low iron state is associated with reduced tumor promotion in a two-stage mouse skin carcinogenesis model
G Bhasin, H Kauser, M Athar
Biochemical and Biophysical Research Communications
|
July 17, 1995
Ferric nitrilotriacetate (Fe-NTA) is a potent hepatic tumor promoter and acts through the generation of oxidative stress
M Iqbal, U Giri, M Athar
Nutrition (Burbank, Los Angeles County, Calif.)
|
September 1, 1995
Novel copper superoxide dismutase mimics and damage mediated by O2.-
M Athar, M Iqbal, U Giri
Basic & Clinical Pharmacology & Toxicology
|
November 2, 2020
LC-MS-sMRM method development and validation of different classes of pain panel drugs and analysis of clinical urine samples
M Athar Masood, Timothy D Veenstra
Page
of 14